Interleukin-17A (IL-17A), a characteristic cytokine of Th17 cells, induces proliferation of primary AML cells due to high expression of IL-17A receptor (IL-17R) on the cell surface. This evidence concerns the gene IL17A and acute myeloid leukemia.